urine.

Страницы: 1 | 2

• I. ACE INHIBITORS
  Since their introduction in 1980, angiotensin-converting enzyme (ACE) inhibitors, because of their unique pharmacologic properties, have proven superior to other vasodilators in the management of heart failure and have come to play a key role in the therapy of hypertension. They are particularly useful in hypertensive patients with diabetes and proteinuria.
• II. ANGIOTENSIN II RECEPTOR BLOCKERS
  Angiotensin II receptor blockers (ARBs) have beneficial effects similar to those of ACE inhibitors, but angioedema occurs less, and cough rarely occurs compared to ACE inhibitors.
• BIBLIOGRAPHY
  Bourassa, M. G. et al. Angiotensin II inhibition and prevention of atrial fibrillation and stroke. J. Am. Coll. Cardiol., 45:720–721, 2005.